Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Research & Development In Brief

This article was originally published in The Tan Sheet

Executive Summary

Magnesium could lower stroke risk; PPI use linked to hip fractures; Supplements could ease ADHD; Alpha-lipoic acid protects neurons

You may also be interested in...



Research & Development In Brief

Long-term PPI use may not accelerate bone density loss; resveratrol could help control diabetes symptoms; vitamin D may reduce respiratory infections; low-dose aspirin stands out versus high, post stent.

Research & Development In Brief

Long-term PPI use may not accelerate bone density loss; resveratrol could help control diabetes symptoms; vitamin D may reduce respiratory infections; low-dose aspirin stands out versus high, post stent.

Public Citizen Urges FDA To Add Sweeping Warnings To PPI Labels

Public Citizen petitions FDA to add several warnings to all proton pump inhibitors, including OTCs – which the agency previously determined do not pose the same level of risk as prescription versions.

Related Content

Topics

UsernamePublicRestriction

Register

PS105563

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel